Results 171 to 180 of about 35,489 (280)
LukS-PV targeting C5aR inhibits EMT in hepatocellular carcinoma via the BCL6/HDAC6/HSPD1 axis. [PDF]
Ding P +11 more
europepmc +1 more source
BCL6 Immunohistochemical Expression In Diffuse Large B Cell Lymphoma [PDF]
Zeina Zuhair Mohammed Jameel +1 more
openalex +1 more source
Acalabrutinib treatment in relapsed/refractory primary cutaneous diffuse large B cell lymphoma, leg type. Case report. [PDF]
Martinez-Gamboa DA +6 more
europepmc +1 more source
Impact of B cell receptor activation and epigenetic regulation on TOSO - a novel NF-κB and BCL6 target gene in Chronic Lymphocytic Leukemia [PDF]
Schulz, Alexandra
core
Correlation of c-MYC, BCL2 and BCL6 proteins overexpression with prognosis in Syrian DLBCL Patients
Background and Aim: c-MYC is a potent transcription factor involved in several cellular processes, and is overexpressed in many cancers, including non-Hodgkin lymphoma (NHL). The most common subtype of NHL is diffuse large B-cell lymphoma (DLBCL). DLBCL
Sulaf Ahmad Farhat Maghrabi +1 more
doaj
Engineering Tfh-Specific Nanoadjuvant to Counteract Bile Acid-Induced Mitophagy and Vaccine Hyporesponsivenes. [PDF]
Wu H +11 more
europepmc +1 more source

